Safety Study of the Rapid System for Acute Ischemic Stroke

Status

Completed

Phases

Phase 1

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT01404403

Enrollment

Registered

2011-07-28

Start date

2011-08-31

Completion date

2013-10-31

Last updated

2013-11-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Ischemic Stroke

Brief summary

This is a safety study of the Rapid System for acute ischemic stroke.

Interventions

DEVICERapid System

Study design

Allocation

NON_RANDOMIZED

Intervention model

SINGLE_GROUP

Primary purpose

TREATMENT

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

18 Years to 85 Years

Healthy volunteers

Inclusion criteria

* Patients ≥18 to \<85 years old * Pre stroke modified Rankin Scale (mRS) of ≤2 * A signed informed consent by patient or a legally acceptable representative

Exclusion criteria

* Pre-stroke life expectancy of less than 6 months * Current participation in another investigational drug or device study * Pregnancy

Design outcomes

Primary

Measure	Time frame
Percentage of participants with Adverse Device Effects (ADEs) Percentage of participants with Adverse Device Effects (ADEs)Percentage	12 patients

Countries

Sweden

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026